OTCM
CBDY
Market cap308kUSD
Oct 08, Last price
0.00USD
1D
-28.57%
1Q
-44.44%
IPO
-89.36%
Name
Target Group Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Target Group Inc. operates within the Canadian cannabis sector, managing the entire lifecycle from cultivation and processing to the distribution of carefully selected cannabis products for both adult medical and recreational consumers. Their extensive product portfolio encompasses traditional cannabis flower, vaporizer-compatible extract pods, and pre-rolls. They also offer a diverse array of innovative infused products, including K-cup compatible coffee and tea pods, beverages, edibles, and topical applications, in addition to a line of CBD wellness items. A notable proprietary product is "Wisp," a unique single-use, pre-measured pod and vaporizer system designed for consumers seeking to vaporize natural botanical herbs, including cannabis. Target Group holds a collaborative agreement with cGreen, Inc. for the manufacturing and distribution of "True Focus," a patent-pending THC antidote, across the United States, Europe, and the Caribbean regions. Further expanding its reach, the company also maintains distribution, collaboration, and licensing arrangements with Serious Seeds B.V. Originally incorporated in 2013, the entity underwent a name change from Chess Supersite Corporation to Target Group Inc. in July 2018. Its operational base is situated in Hamilton, Canada.
Key people
Barry Alan Katzman
Co-Chief Executive Officer, Director · since 2019
Saul Niddam
Director · since 2019
Rubin Schindermann
Chief Executive Officer, Director · since 2019
Legal address
C/O Inc. Plan (USA)
Trolley Square
Suite 20C
Wilmington, DE 19806
US
Trolley Square
Suite 20C
Wilmington, DE 19806
US
Headquarters
1131A Leslie Street
Suite 101
Toronto, ON M3C 3L8
CA
Suite 101
Toronto, ON M3C 3L8
CA
Previous name
River Run Acquisition Corporation
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||